The Medicines and Healthcare products Regulatory Agency (MHRA) approved marketing authorisation for Mounjaro, a new treatment, to manage type 2 diabetes in adults. This authorization comes after encouraging results from clinical trials that showed Mounjaro significantly reduces blood sugar levels in patients. Mounjaro is a a once-weekly injection